Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1366
| Despition | Dopamine D5 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1133 | Synthetic Nanodisc Human OR52D1 Protein (AC1133) | 10 µg | inquiry |
| ACPP-1729 | Human OCM Protein (AC1729) | 2 µg | inquiry |
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1810 | Rat LIF Protein (AC1810) | 2 µg | inquiry |
| ACPP-1038 | Recombinant Human VCAM1 Protein (6×His Tag) (AC1038) | 50 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
| ACPP-1479 | Human TIMP1 Protein, HEK (AC1479) | 2 µg | inquiry |
| ACPP-1680 | Human DOK4 Protein (AC1680) | 5 µg | inquiry |
| ACPP-1488 | Mouse CNTF Protein (AC1488) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.